Europe Pharmacovigilance and Drug Safety Software Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Pharmacovigilance and Drug Safety Software Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Pharmacovigilance and Drug Safety Software Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Pharmacovigilance and Drug Safety Software Market Regional Analysis

6.2 Europe Pharmacovigilance and Drug Safety Software Market Revenue 2021-2031 (US$ Million)

6.3 Europe Pharmacovigilance and Drug Safety Software Market Forecast Analysis

7. Europe Pharmacovigilance and Drug Safety Software Market Analysis – by Offering

7.1 Software

7.1.1 Overview
7.1.2 Software: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021-2031 (US$ Million)

7.2 Services

7.2.1 Overview
7.2.2 Services: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Pharmacovigilance and Drug Safety Software Market Analysis – by Deployment

8.1 Cloud

8.1.1 Overview
8.1.2 Cloud: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021-2031 (US$ Million)

8.2 On-Premises

8.2.1 Overview
8.2.2 On-Premises: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Pharmacovigilance and Drug Safety Software Market Analysis – by Enterprise Size

9.1 Large Enterprises

9.1.1 Overview
9.1.2 Large Enterprises: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021-2031 (US$ Million)

9.2 SMEs

9.2.1 Overview
9.2.2 SMEs: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021-2031 (US$ Million)

10. Europe Pharmacovigilance and Drug Safety Software Market Analysis – by Form

10.1 Standard

10.1.1 Overview
10.1.2 Standard: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021-2031 (US$ Million)

10.2 Customized

10.2.1 Overview
10.2.2 Customized: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021-2031 (US$ Million)

11. Europe Pharmacovigilance and Drug Safety Software Market – Europe Analysis

11.1 Overview

11.2 Europe

11.2.1 Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Country, 2024 and 2031 (%)
11.2.1.1 Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Country
11.2.1.1 Germany: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.1.1 Germany: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
11.2.1.1.2 Germany: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
11.2.1.1.3 Germany: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
11.2.1.1.4 Germany: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Form

11.2.1.2 France: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.2.1 France: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
11.2.1.2.2 France: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
11.2.1.2.3 France: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
11.2.1.2.4 France: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Form

11.2.1.3 Italy: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.3.1 Italy: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
11.2.1.3.2 Italy: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
11.2.1.3.3 Italy: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
11.2.1.3.4 Italy: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Form

11.2.1.4 UK: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.4.1 UK: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
11.2.1.4.2 UK: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
11.2.1.4.3 UK: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
11.2.1.4.4 UK: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Form

11.2.1.5 Spain: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.5.1 Spain: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
11.2.1.5.2 Spain: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
11.2.1.5.3 Spain: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
11.2.1.5.4 Spain: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Form

11.2.1.6 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)

11.2.1.6.1 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
11.2.1.6.2 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
11.2.1.6.3 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
11.2.1.6.4 Rest of Europe: Europe Pharmacovigilance and Drug Safety Software Market Breakdown, by Form

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Veeva Systems Inc

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 IQVIA Holdings Inc

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 AB Cube S.A.S.

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 ArisGlobal LLC

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Oracle Corp

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Max Application

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 ICON Plc

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Cognizant Technology Solutions Corp

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Accenture Plc

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Syneos Health Inc

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

14.11 Genpact Ltd.

14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments

14.12 Laboratory Corp of America Holdings

14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments

14.13 Parexel International Corp

14.13.1 Key Facts
14.13.2 Business Description
14.13.3 Products and Services
14.13.4 Financial Overview
14.13.5 SWOT Analysis
14.13.6 Key Developments

14.14 Qinecsa Solutions

14.14.1 Key Facts
14.14.2 Business Description
14.14.3 Products and Services
14.14.4 Financial Overview
14.14.5 SWOT Analysis
14.14.6 Key Developments

14.15 Clinevo Technologies

14.15.1 Key Facts
14.15.2 Business Description
14.15.3 Products and Services
14.15.4 Financial Overview
14.15.5 SWOT Analysis
14.15.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Europe Pharmacovigilance and Drug Safety Software Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis